Inhibition of P-gp function and/or expression by TCM
Compound | Test Model | Pharmacological Results | References |
---|---|---|---|
Flavonoids | |||
EGCG | CEM/ADR | Downregulation of P-gp | Li et al., 2018 |
GQ | MCF-7/ADR | Downregulation of P-gp and MDR1 gene | Zhang et al., 2019 |
Silymarin A | A2780/ADR | Inhibition of P-gp efflux; downregulation of P-gp | Viktorova et al., 2019 |
Dihydromyricetin | MCF7/ADR; K562/ADR | Inhibition of P-gp efflux; downregulation of P-gp | Sun et al., 2018 |
Curcumin | KB-C2 | Inhibition of P-gp | Lopes-Rodrigues et al., 2016 |
Apigenin | CEM/ADR | Inhibition of P-gp | Saeed et al., 2015 |
Taxifolin | HeLaS3; KB/VCR | Inhibition of P-gp | Chen et al., 2018 |
Alkaloids | |||
Chelidonine | Caco-2; CEM/ADR | Inhibition of P-gp | Herrmann et al., 2018 |
Tetrandrine | MCF-7/ADR | Downregulation of P-gp | Liao et al., 2019 |
Matrine | MCF-7/ADR | Inhibition of P-gp | Zhou et al., 2018 |
Terpenoids | |||
Ursolic acid | MCF-7/ADR | Inhibition of P-gp | Zong et al., 2019 |
Parthenolide | A549/ADR | Downregulation of P-gp | Carlisi et al., 2017 |
Costunolide | K562/ADR | Downregulation of P-gp | Cai et al., 2019 |
Cryptotanshinone Dihydrotanshinone | CEM/ADR | Downregulation of P-gp and MDR1 gene | Hu et al., 2014 |
Coumarins | |||
Galbanic acid | HL60 | Inhibition of P-gp | Maruszewska and Tarasiuk, 2019 |
Decursinol | NCI/ADR-RES | Inhibition of P-gp | Choi et al., 2016 |
Osthole | K562/ADR | Downregulation of MDR1 gene | Wang et al., 2016 |
Quinonoids | |||
Miltirone | HepG2 | Inhibition of P-gp | Zhou et al., 2015 |
Emodin | K562/ADR; Caco-2 | Downregulation of P-gp | Min et al., 2017 |
Shikonin | A2780/PTX | Inhibition of P-gp | Wang et al., 2019 |
TCM extracts | |||
Asiatic toad | CRC | Inhibition of P-gp | Yuan et al., 2017 |
S. miltiorrhiza | Everted rat gut sacs | Inhibition of P-gp | Dai et al., 2012 |
S. chinensis | K562/A02 | Downregulation of P-gp; inhibition of P-gp | Wang et al., 2017 |
CR | LS180 | Activation of P-gp transportation | Yu et al., 2018 |
Liquorice | Caco-2 | Inhibition of P-gp | He et al., 2020 |
CRC, colorectal cancer cell; EGCG, epigallocatechin-3-gallate; VCR, vincristine.